View Press Releases
-
Breakthrough towards protein sequencing using Oxford Nanopore holds promise for disease research and drug development
In a research collaboration with Oxford Nanopore Technologies, scientists from the University of Washington have unveiled a groundbreaking ‘proof-of-concept’ method for reading single protein molecules
Sep 10, 2024
-
Cleveland Diagnostics’ Prostate Cancer Awareness Campaign ‘A PSA on PSA’ Returns This September
National Initiative to Increase Education & Awareness; Raise Funds for ZERO Prostate Cancer with Donation Made for Every Patient Discussion Guide Downloaded at PSAonPSA.com
Sep 10, 2024
-
PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments
PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the launch of MET Predict† on the AISightⓇ† Image management system (IMS). MET Predict is an AI-powered algorithm designed to help pathologists identify non-small cell lung cancer (NSCLC) tumors that may be more likely to have MET exon 14 skipping (METex14) or MET amplification, directly from an H&E whole slide image.
Sep 9, 2024
-
PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth
PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth Miami, FL – 10th September 2024, PharmaForceIQ (PFIQ), the leading end to end Omnichannel Solution for Pharmaceutical Marketing, Medical and Clinical teams today announced a significant investment by Eir Partners (Eir) to accelerate adoption of the company’s unique technology platform and services for the Life Science industry.
Sep 9, 2024
-
Verisense Health Introduces an iOS App for its Smart Watch
The Verisense Smart Watch, Which Collects Digital Health Data During Clinical Trials, is Now Compatible with Both Apple and Android Smartphones.
Sep 9, 2024
-
Quotient Sciences and Vasa Therapeutics Announce Dosing of First Subjects with VS-041, a Novel Heart Failure Treatment
-
Envision Pharma Group launches EnvisionOne Insights: A unified data and analytics solution for medical affairs
One of the world’s leading technology solutions companies Envision Pharma Group has launched “EnvisionOne Insights” an innovative medical technology solution for the power of big dat
Sep 10, 2024
-
APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology
-
Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions with Launch of New Archer™ HRD Technology for Cancer Research
-
Life Sciences Organizations Gain New Real-World Data Offering To Bring Precision Therapies And Diagnostics To Patients
Proscia customers can leverage over 10 million de-identified pathology images alongside corresponding clinical and genomic data
Sep 3, 2024
-
Global CDMO brings technological advancements & significant capacity to Ocean County, NJ location
-
Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair
Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair
Sep 4, 2024
-
Medical University of Graz Selects the HALO AP® Digital Pathology Platform to Deliver Comprehensive Diagnostics
Indica Labs has announced the Diagnostics & Research Institute for Pathology at the Medical University of Graz has selected the HALO AP® digital pathology platform from Indica Labs to deliver primary diagnostics, alongside Aperio GT 450 scanners from Leica Biosystems.
Sep 5, 2024
-
FDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion’s First Commercial Test
Novel assay detects misfolded α-syn in cerebrospinal fluid; A critical drug development tool that can enhance clinical trials and advance life-changing treatments for PD and other neurodegenerative disorders
Sep 4, 2024
-
SPT Labtech and Synthace partner to accelerate drug discovery through accessible DOE
-
InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling
InSysBio launches Immune Response Template (IRT) version 3.6.3. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system. Veronika Musatova, Head of IRT development team, comments on the new version, “As a result of the update, B cells model reflects the current views on the processes and sequence of this cell type development maintaining a balance between the model detail and complexity.”
Sep 3, 2024
-
VedaBio Appoints Dr. G. Brett Robb as Senior Scientific Director and Head of CRISPR Science
VedaBio Appoints Accomplished Leader, Dr. G. Brett Robb, as Senior Scientific Director and Head of CRISPR Science to Drive Platform Expansion and Industrialization
Sep 3, 2024
-
Sapio Sciences Advances The World's First AI-Powered Lab Assistant
Sapio Sciences today announced significant enhancements to Sapio ELaiN, the pioneering AI-powered lab assistant that helps scientists streamline processes and work more efficiently. Sapio ELaiN is also now generally available after a successful beta launch in November 2023.
Sep 2, 2024
-
Enzene appoints new site Lead for Flagship US continuous bioManufacturing facility
-
Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination
Phreesia and the American Academy of Pediatrics (AAP) have joined forces to increase measles, mumps and rubella (MMR) immunization by reaching parents and caregivers of eligible or soon-to-be eligible children at the point of care. The collaboration comes as immunization rates have dipped in some communities, pointing to a need to improve access to the vaccines that can help keep children healthy.
Aug 28, 2024